Berubicin
- Generic Name
- Berubicin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C34H35NO11
- CAS Number
- 677017-23-1
- Unique Ingredient Identifier
- 6QPN83HK2M
- Associated Conditions
- -
- Associated Therapies
- -
CNS Pharma's Berubicin Shows Higher Patient Retention in Pivotal GBM Trial
CNS Pharmaceuticals presented updated results from its pivotal study comparing Berubicin vs Lomustine in recurrent GBM patients, showing higher completion rates (84.7% vs 78.9%) and lower withdrawal rates (11.0% vs 19.7%) in the Berubicin arm. Safety profiles were similar, with slightly higher anemia and neutropenia rates in Berubicin and more thrombocytopenia in Lomustine. Primary analysis data is expected in H1 2025.
Related Clinical Trials:
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath